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Abstract
Introduction and Purpose: In chronic heart failure (CHF), exercise rehabilitation results in a
reduced risk of mortality, decreased disease severity, and increased functional ability.  Resistance
training is an important component of cardiac rehabilitation; however, an optimal training
velocity that produces physiological and functional benefits at minimal perceived exertion and
cardiovascular stress has yet to be identified. CHF patients need to be very efficient and perform
the exercise that will give them the greatest benefits because of their poor exercise tolerance and
increased risk of cardiovascular complications during exercise. In older populations, high
velocity resistance training results in greater improvements in functional ability than low velocity
resistance training. The use of high velocity resistance training in patients with CHF has yet to be
examined; however it may enhance higher velocity activities of daily living while using a lower
training load. The lower load associated with high velocity training may be less strenuous and
result in lower cardiovascular stress, whilst maintaining a relatively similar power output
compared to traditional low-velocity training. The purpose of this study was to compare the acute
cardiovascular responses and perceived exertion of high and low velocity resistance exercises.
Methods and Measures: 6 male and 1 female patients with systolic heart failure (CHF NYHA
Class I-III) were recruited to perform two separate, randomly assigned exercise sessions.  These
sessions consisted of 5 exercises (hack squat, chest press, knee flexion, lat pull down and knee
extension); one with a low velocity of contraction (3 second concentric phase: 3 second eccentric
phase at 50% of the slow velocity 1-RM) and one with a high velocity (1 second concentric
phase: 3 second eccentric phase at 50% of the high velocity 1-RM). During both sessions, heart
rate, blood pressure, and a rating of perceived exertion (RPE) were obtained after the completion
of each exercise.
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Results: Despite a similar relative mechanical load, the high velocity workout produced
significantly lower systolic blood pressure (121.2 vs. 132.8 mmHg), mean arterial pressure (87.8
vs. 93.5), and RPE (3.7 vs.4.8) than the low velocity workout (p<0.05).  The high velocity
workout was not significantly different from the low velocity workout for heart rate, rate
pressure product and diastolic blood pressure.
Conclusion: We conclude that the high velocity workout produces more favourable blood
pressure responses to resistance training in patients with CHF than the low velocity workout and
may be used to enhance functional outcomes in cardiac rehabilitation programs.
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1Chapter 1
Scientific Framework
1.1 Context
There are approximately 400,000 Canadians living with chronic heart failure (CHF) and
the number of cases are increasing1. More severe CHF (as typically determined by a worse New
York Heart Association (NYHA) classification) is associated with an increased risk of death 2.
The NYHA classification system ranks the disease progression of Patients with CHF based on
the severity of their symptoms. Exercise training is associated with an improvement in NYHA
classification in Patients with CHF2. Specifically, resistance training is important for patients
with CHF because it strengthens their weakened muscles without putting a load on their heart
and thus limits their activity3.  Optimal training programs that produce physiological and
functional benefits at minimal perceived exertion and deleterious cardiac stress have yet to be
identified.  In healthy older adult populations, high velocity resistance training has been
compared to low velocity resistance training and has been shown to result in greater
improvements in muscle power and functional performance4, 5. However, high and low velocity
resistance training have yet to be compared in patients with CHF.
1.2 Objective
The objective of this study was to compare the acute heart rate and blood pressure
responses and perceived exertion during high and low velocity resistance exercises in patients
with CHF.
21.3 Literature Review
1.3.1 Chronic Heart Failure
CHF is a complex syndrome in which abnormal heart function results in signs of low
cardiac output and/or pulmonary or systemic congestion2.  In simpler terms, the heart is unable to
pump an adequate amount of oxygenated blood for the normal functions of the body. Patients
with CHF can suffer from systolic dysfunction and/or diastolic dysfunction6. I will be focusing
on patients with systolic dysfunction. In systolic dysfunction heart failure, damage to the heart
results in a poor contractility of the ventricle, which leads to impaired blood flow6. It is
characterized by a left ventricular ejection fraction (LVEF) of less than 35-40% and left
ventricular dilation (diastolic diameter >5.6 cm at end-diastole) as assessed by
echocardiography7.
The NYHA functional classification model is used to determine the cardiovascular event
risk levels in patients with CHF based on the severity of their symptoms, such as undue fatigue,
palpitations, dyspnoea, or angina at rest and during physical activity. Class I patients with CHF
have no symptoms; class II have symptoms with ordinary activity; class III have symptoms with
less than ordinary activity; and class IV have symptoms at rest or with any minimal activity 2.
Class I and II patients will only be recruited for this study because they are at a lower risk for
cardiac complications. Examining heart rate and blood pressure responses to exercise can reflect
the stress on the cardiovascular system and the degree of risk associated with the exercise being
performed.
The reduction in oxygen delivery that occurs in patients with CHF decreases quality of
life, exercise tolerance, and survival; CHF is associated with an annual mortality of 5% - 50%,
depending on the severity of symptoms, heart dysfunction, and age2.  These consequences of
3CHF are due to both cardiac limitations and peripheral mal-adaptations of the skeletal
musculature.  The cardiac limitations include left ventricular impairment. The skeletal muscle
mal-adaptations include: a reduction in the peripheral blood flow and impaired perfusion and
deficiencies in skeletal muscle function, morphology, and metabolism8. The deterioration of
skeletal musculature increases cardiovascular stress, increases symptoms, and further reduces
exercise capacity8. Resistance training is a method used to maintain or increase skeletal muscle
function and mass and can be extremely beneficial for patients with CHF to combat the
aforementioned symptoms3.
Initial interventions for CHF recommended against exercise or any type of strenuous
activity.  The deleterious effects of both CHF and inactivity prompted research to be conducted
on exercise training for patients with CHF.  Endurance training was first investigated, followed
by resistance training, and combined endurance and resistance training programs.  Acute studies
that demonstrated the safety of exercise training were followed by studies of exercise
interventions that also confirmed the relative safety of exercise training.
1.3.2 The Safety of Resistance Training
The safety of low velocity resistance training has been thoroughly investigated in patients
with CHF.  In a review by Meyer of 10 studies including 232 patients with CHF, the incidences
of adverse events were low3.  In only two studies was there an adverse event reported.  Atrial
fibrillation occurred in one study and a sudden death at home three days after the last training
session occurred in the other study.  This rate of adverse events is similar to those reported from
training programs in CHF that did not include resistance exercises.
The acute physiological responses to resistance training are generally positive.  During
resistance training, left ventricular function is well maintained and the left ventricular response is
4similar to that of endurance exercise9,10.  Central hemodynamics, such as systolic blood pressure
(SBP), diastolic blood pressure (DBP), heart rate (HR), and cardiac output remain relatively
stable throughout a resistance training session10.  The hemodynamic burden is even lower during
resistance exercise than in maximal and sub-maximal aerobic exercise11.  The pattern of both
hemodynamics and left ventricular responses to a set of a resistance exercise in patients with
CHF is similar to that of young healthy adults12. Myocardial function remains stable with no left
ventricular deterioration during upper and lower body exercise1-RM testing, (i.e. evaluating
strength by measuring the maximal amount of weight that can be lifted once using a specified
movement pattern with a specified velocity) in patients with CHF making this type of testing
acceptable12,13.
The positive findings of the acute studies allowed resistance exercise interventions to be
studied to ensure that long term resistance exercise was also safe.  Left ventricular function and
structure, pro-inflammatory cytokines, cytokine receptors, and the N-terminal fragment of brain
nutiuretic peptide (NT-proBNP) have been studied to confirm the safety of resistance training.
These measurements are explained below in more detail.
The measurements of left ventricle structure include left ventricular end diastolic
diameter and left ventricle end systolic diameter. Ejection fraction, stroke volume and fractional
shortening can be calculated from these measurements to assess left ventricular function.
Measurements of left ventricular function and structure are typically analyzed using
echocardiography or radionuclide ventriculography.  In systolic heart failure, the ventricles alter
their size and geometry in response to chronic changes in hemodynamic load14.  As a result the
left ventricular end diastolic and end systolic diameters are increased in CHF because of
retention of fluids caused by poor systolic function.  A pathological increase in either diameter is
5associated with a progression of the disease. Low velocity resistance training and combined
resistance and endurance training either maintain15,16,17 or decrease both diameters18,19,20.  The
maintenance is a positive outcome because in cases where a non-exercising control group was
utilized, conditions worsened in the control group16. Resistance training improves or maintains
measures of left ventricular function such as ejection fraction, stroke volume and fractional
shortening15,21,16,19.
Higher levels of pro-inflammatory cytokines such as tumor necrosis factor α (TNF-α) and
interleukin-6 (IL-6) are present in patients with CHF22.  These two cytokines are associated with
left ventricular remodelling during the progression of the disease. TNF-α induces the formation
of oxygen free radicals which destroys nitric oxide produced in the endothelium22. The
destruction of nitric oxide, a vasodilator, will lead to increased peripheral resistance causing an
increase in stress on the heart by increasing blood pressure. Conraads et al. found that after a
combined resistance and endurance training program cytokine levels remained the same and
cytokine receptors, specifically soluble TNF-α receptor-1, decreased22.  The stability of the
cytokine levels adds more support for the safety of resistance training.  The decrease in TNF-α
receptor-1 suggests that the exercise training had an anti-inflammatory effect on both central and
peripheral vasculature.
Brain natiuretic peptide (BNP) and NT-proBNP are secreted by ventricular
cardiomyocytes (cardiac muscle cells) and reflect left ventricular diastolic wall stress23. They are
also predictors of mortality and treatment success in CHF24,25. Four months of combined
endurance and resistance training reduced NT-proBNP levels18. A decrease in left ventricular end
systolic and diastolic diameters was also present which means that a lower diastolic wall stress
could have caused the decrease in NT-proBNP secretion18. In summary, exercise training has a
6beneficial effect on left ventricular remodelling and is safe for patients with CHF.
1.3.3 The Benefits of Resistance Training
There are numerous benefits for patients with CHF to participate in resistance training
programs. Maintenance of most outcome measures is seen as positive because in most cases non-
exercising control groups with CHF will deteriorate in function26,27,19.  NYHA classification,
functional status and quality of life improve with exercise training15,22,28.  Changes in functional
status are often assessed by improvements in 6-minute walk distance29,30.  Changes in quality of
life have most frequently been assessed by the Minnesota Living with Heart Failure
Questionnaire32,19,17. Resistance training also improves peak oxygen consumption (VO2) (10-
17%)26,32,19,27. In NYHA functional class II and III patients with CHF, peak VO2 is between 12
and 19 ml∙kg-1∙min-1 or 40-55% of age matched controls33. Improving peak VO2 is important
because older people tend to lose their functional independence when VO2 falls below 15 ml∙kg-
1∙min-1 34. These improvements can be traced back to other physiological characteristics that have
benefited from resistance training, including improved muscular strength and endurance,
sympathovagal balance, and central hemodyanmics.
Significant improvements in muscular strength (15-43%) and muscular endurance (18-
299%) occurred after resistance training29,35,30,21,26,32,19.  These improvements have been
attributed to morphological and histochemical changes in skeletal musculature.  Morphological
changes include an increased muscle fibre area and capillary per fibre ratio36. Feiereisen et al.,
found a 4% increase in thigh muscle volume after programs that included resistance training
whereas the non-exercising control group encountered a decrease of 2%19. Increases in forearm
blood flow have been attributed to the increased capillary density and an improvement in
vascular function29,31,26.  Maiorana et al. found improvements in forearm blood flow despite
7focusing on avoiding any exercises that includes use of the forearms31.  This suggests the
beneficial effect of exercise on vascular function may be generalized and not specific to the
vascular bed of the trained skeletal muscle.  In the same study, endothelium- dependent
vasodilation to acetylcholine and endothelium-independent vasodilation to sodium nitroprusside
significantly increased which demonstrates the improvement in vascular function after resistance
training31. This improvement is important because patients with CHF suffer from vascular
dysfunction causing a reduced vasodilatory response37.
Histochemical improvements have contributed to the improvements in muscular
endurance.  After a 3-month resistance training program, Williams et al. found increases in
several indices of muscle oxidative capacity27. A decrease was found in the non-exercising
control group.  The markers of oxidative capacity included mitochondrial ATP production rate
and oxidative enzymes citrate synthase (a marker of the Krebs Cycle) and β-hydroxyacyl
coenzyme A dehydrogenase (a marker of fatty acid oxidation).
Heart rate variability has been used to study the sympatho-vagal balance in patients with
CHF.  Increased stimulation of the sympathetic nervous system and decreased activity of the
parasympathetic nervous system occurs in patients with CHF, which causes an increase in resting
HR, vasoconstriction in the peripheries and depressed heart rate variability38,39,40,41. A decreased
heart rate variability is a strong and independent predictor of ventricular fibrillation and sudden
cardiac death42. Resistance training improves the sympathovagal balance in patients with CHF
and causes heart rate variability to increase26.
Resistance training, and combined resistance and endurance training programs are also
beneficial for central hemodynamics.  Resting HR, maximum HR, rate pressure product and
stroke volume all change in response to exercise programs.  Resting HR decreases because of the
8decreased stimulation of the sympathetic nervous system15,18. Another symptom of CHF is
chronotropic incompetence; which is defined as the inability of the heart to increase its rate in
proportion to exercise and meet the metabolic demands of the body.  In a clinical setting,
chronotopic incompetence is defined as less than 80% of the age-predicted maximum HR in
response to exercise in the presence of a respiratory exchange ratio of greater than 1.0 and a
plateau in oxygen consumption43. An increase in maximal HR occurs with resistance training and
is thought to be caused by the improvement in leg strength; which allows an increase in exercise
time.  By exercising for a longer period, it allows plasma norepinephrine levels to increase for a
longer duration and to exert its chronotropic effect44,18. Rate pressure product (RPP) is the
product of HR and SBP; it has been used as a marker for myocardial oxygen consumption which
reflects how hard the heart has to work. RPP has a high correlation with myocardial oxygen
consumption assessed with arterial catheterization (r = 0.88 - 0.90)45,46. Rate pressure product
decreases suggesting a decrease in myocardial oxygen demand possibly caused by an increase in
peripheral vasodilation and a decrease in afterload following exercise35. This suggests a
decreased work stress on the heart.
1.3.4 Current Resistance Training Guidelines
Research examining the optimal components of resistance training for patients with CHF
is still ongoing. Different modes, intensities and loads have been studied for their safety and
effectiveness.  Meyer stated that resistance training is well tolerated when initial contraction
intensity is low, small muscle groups are involved, work phases are kept short, a small number of
repetitions per set is performed and a work to rest ratio is greater than 1:23. Volaklis and
Tomakidis suggested that intensity for NYHA Class I-II patients should start at 50-60% of 1-RM
using machine weights and a perceived exertion rating should range from 'fairly light' to
9'somewhat hard' on the Borg scale8.  For duration, they recommend that work phases should not
last longer than 60 seconds and an entire session should range from 20 to 30 minutes.  The mode
they suggest is bilateral whole body resistance training for NYHA class I patients and segmental
unilateral training for NYHA II-III patients. Segmental unilateral training produces a lower
hemodynamic response compared to bilateral whole body training allowing the higher class
patients to not be overburdened during resistance exercise. Volaklis and Tomakidis recommend
4-6 seconds (2-3 for the concentric phase and 2-3 for the eccentric phase) for the tempo of the
contraction8.  This recommendation is solely based on previous studies that have only used that
range of velocities.  The impact of different velocities of contraction has been researched in only
one acute study.  Degache et al. found that HR and blood pressure responses were not different
between 60º/s and 180º/s when performing 2 sets of 3 repetitions of knee extension and flexion47;
however, the resistance training was performed on an isokinetic dynamometer which would elicit
maximal contractions.  There is a need to investigate the effect of high velocity resistance
training where the power output is matched to slower velocity resistance training.
1.3.5 High Velocity Resistance Training
High velocity resistance training focuses on the concentric phase of a resistance exercise
being performed at a speed of one second or less. High velocity resistance training has been well
studied in the older adult population and is associated with greater improvements in peak power,
muscular power, and whole body physical function than low velocity training programs 48,2,3.
Muscle peak power, which is the target of high velocity training, is more closely related to the
ability to perform activities of daily living than muscle strength, which is the target of traditional
or low velocity training49.  In most of the research studies performed on this subject, the training
programs were not matched for power output or total workload per session.  The participants in
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the high velocity training programs typically performed lower total workloads than the low
velocity participants.  Despite the difference, both training programs similarly enhanced multiple
components of muscle function and functional performance50,51. In CHF, this result can still be of
value. A patient with CHF has a reduced exercise capacity at baseline and if they can receive the
same benefit of a traditional low velocity workout from a high velocity workout at a lower work
output, they may incur less cardiovascular stress and become less fatigued. There is a possibility
that by matching power output, a high velocity workout may result in greater functional
improvements, or that a high velocity workout at a lower workload may produce similar
improvements but cause less cardiovascular strain and perceived effort.
1.3.6 Cardiovascular Responses to Resistance Training
The cardiovascular responses in patients with CHF to resistance training have been
examined sparingly and with varied resistance training protocols. The protocols differ in mode;
i.e. isokinetic dynamometry47 vs. isotonic52,10,11,12,13 load, velocity of contraction, workload
(number of sets and repetitions), exercise used (leg press, knee extension, knee flexion, biceps
flexion, and shoulder press), and disease severity of the population studied (NYHA
Classification). Cardiovascular responses to resistance training in the healthy population have
been studied more thoroughly but the resistance training protocols are just as varied as the
studies with patients with CHF.  The results are consistent despite the differences in protocols
being used.
In patients with CHF, HR significantly increases during a set of resistance exercise52,10. In
healthy adults, the HR during one repetition of resistance exercise increases during the
concentric portion of a lift and decreases slightly during the eccentric portion53. The magnitude
of the HR response corresponds to the amount of effort required to lift a weight53. While lifting
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an absolute weight a greater effort is required during the concentric phase than during the
eccentric phase.  A greater effort corresponds to a greater number of motor units required for the
resistance exercise. The more motor units required, the more muscle mass being used, and a
greater blood flow at the muscle is required54. During a set of resistance exercise, the highest HR
is recorded during the concentric phase of the last repetition when the greatest numbers of motor
units are recruited55,53.  HR rises to increase the cardiac output to meet demands and to
compensate for a decrease in stroke volume54. The decrease in stroke volume is due to an
increase in total peripheral resistance throughout the set because of an increase in intramuscular
pressure. The intramuscular pressure reduces venous return which reduces stroke volume54.
In patients with CHF, HR is greater during lower body vs. upper body exercises11, when
more muscle mass is involved13, when a greater load (up to 100% of 1-RM) is used, and a greater
number of repetitions and sets are performed47. These results can be explained by an increase in
motor unit recruitment that requires a higher cardiac output. HR in patients with CHF is also
influenced by their degree of left ventricular impairment. The greater the left ventricular
impairment, the greater the HR response to a set of resistance exercise.  In those with severe
impairment, stroke volume decreases as exercise intensity increases and in order to meet
demands HR increases to raise cardiac output11.
SBP, DBP, and mean arterial pressure (MAP) all significantly increase during resistance
training in patients with CHF52,10. The mechanisms as to why this occurs have been more closely
examined in healthy adults.  Similar patterns occur between SBP, DBP and MAP as HR during
one repetition and over the course of a set where highest blood pressures are seen during the
concentric phase of the lift and the last repetition of the set. SBP is influenced by the number of
sets performed, the rest interval, the load56,57,58,59, and the size of muscle mass60. The greater
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number of sets performed, load, and muscle mass and the smaller the rest interval the greater the
SBP response. The increase in SBP is related to the increase in HR that occurs61, the exercise
pressor reflex61, and the mechanical compression of the arteries54,62. SBP is a function of cardiac
output multiplied by total peripheral resistance. Cardiac output is a function of HR and SV and
typically when HR increases SBP will increase too. The exercise pressor reflex occurs during
resistance exercise when more blood flow needs to be diverted to the contracting muscle.
Vasoconstriction occurs in non-exercising tissues while arteries in the exercising muscle
vasodilate to increase blood flow to the muscle61. The exercise pressor reflex is exaggerated in
CHF patients causing increases in blood pressure, sympathetic nerve activity, and vascular
resistance 63. Fleck suggests that the exercise pressor reflex occurs when a set of resistance
exercise is performed at 70-95% of 1-RM to failure64. The vasodilation that occurs at the muscle
is opposed by the mechanical compression of the muscle, caused by the contracting muscle,
which occurs when the exercise load is great enough61,54. Local blood flow becomes impeded at
40-60 % of maximal isometric contraction65,66. The vasoconstriction from the exercise pressor
reflex and the mechanical compression of the arteries at the exercising muscle causes an increase
in total peripheral resistance which in turn increases SBP. DBP and MAP respond to resistance
training the same as SBP10,61,53,54,60,67.
1.4 Hypothesis
The hypothesis of this study is that high velocity resistance training will be more
favourable regarding the acute cardiovascular responses and perceived exertion than low velocity
training in patients with CHF. (1) The longer concentric contraction time in the low velocity
session will cause an increase in blood pressures by occluding the blood vessels in the working
muscle. (2) The higher blood pressures will require a higher HR to increase cardiac output to
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match work level because venous return is decreased causing a reduced stroke volume. (3) The
higher HR and blood pressures will cause a greater RPP response and also (4) make the low
velocity session perceive to be more difficult than the high velocity session. The low velocity
resistance training will produce significantly greater HR, SBP, DBP, MAP, rating of perceived
exertion (RPE), and RPP than the high velocity resistance training.
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Chapter 2
Methods
2.1 Participants
A sample of eight CHF patients were approached to participate in this research study.
Seven NYHA Class I (n=4) and Class II (n=3), as determined by a cardiologist, systolic patients
with CHF (6 males, 1 female) between 47 and 75 years of age were enrolled and participated in
this study. All of them were enrolled in Cardiac Rehabilitation at the Saskatoon Field House at
the time of participation. The study was approved by the University of Saskatchewan biomedical
review board for research in human subjects, and all participants gave their written informed
consent prior to data collection. (See Appendix A for a copy of the Ethics: Certificate of
Approval). All testing and training was performed at the Saskatoon Field House Cardiac
Rehabilitation Program. Their mean (±SD) age, height, body weight, Minnesota Living with
Heart Failure Questionnaire (MLHFQ) Score and LVEF can be found in Table 2.1 All
participants were on optimal medical treatment as determined by the primary cardiologist and
were in a stable clinical condition for at least 6 weeks prior to inclusion (see Table 2.2 for a list
of participant medications). Participants were excluded from participating if they were NYHA
Class IV, had any malignant ventricular arrhythmias, advanced renal dysfunction (creatinine
clearance <40), stroke, advanced chronic obstructive pulmonary disease (FEV1 <1.0), or
orthopedic limitations that would prevent them from performing the resistance exercises with
proper form and no pain.
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Table 2.1 Participant Demographics
Data listed as Means ± Standard Deviation
Age
(years)
Weight
(kg)
Height
(cm)
BMI
(kg/m2)
MLHFQ
Score
LVEF
(%)
63.3 ± 8.9 79.3 ± 9.2 168.4 ± 6.9 28.0 ± 3.0 42.4 ± 25.2 28.0 ± 9.2
MLHFQ = Minnesota Living with Heart Failure Quality of Life Questionnaire score
LVEF = Left ventricular ejection fraction
Table 2.2 Participant Medications
Drug Type Participants on Drug Number ofParticipants on Drug
α & β Adrenergic Blocking Agent x, ∗, o, + 4
β-blocker , □, ∆ 3
Aldosterone Receptor Blocker (Diuretic) o, + 2
Angiotensin Converting Enzyme (ACE) Inhibitor □, x ,∗, o 4
Angiotensin II Receptor Antagonist 1
Antiarrhythmic Agent (Class III) , o 2
Anticoagulant (Blood Modifier)
, ∆, x, ∗, o, + 6
Antiplatelet (Blood Modifier) □, ∆, x, + 4
Calcium Channel Blocker ∆ 1
Cardiac Glycoside ∆, x, ∗, + 4
Cholesterol Absorption Inhibitor (Antilipemic Agent) ∆ 1
HMG-CoA Reductase Inhibitor (Antilipemic Agent) , □, ∆, x, ∗, o 6
Loop Diuretic □, ∆, ∗, o, + 5
2.2 Experimental Design
This research study was conducted using a within subject repeated measures design to
assess two different conditions (high vs. low velocity resistance training).  Participants
performed one high velocity resistance training session and one low velocity resistance training
session. The order in which they performed these sessions was randomized and counterbalanced
between subjects.
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Figure 2.1 Study Design
2.3 Training Session
Participants performed a 5-minute warm up before each resistance training session that
involved walking or participating in a full body warm up class led by an exercise therapist at the
Saskatoon Field House Cardiac Rehabilitation Program.  Both resistance training sessions
consisted of five weight machines that were performed in the following order: hack squat, chest
press, knee extension, lat pull downs, and knee flexion. Participants were tested individually. The
training session consisted of one set of 12 repetitions at 50% of their 1-RM for each exercise.
This training session is similar to the start of the programs used by Conraads et al.18, Levinger et
al.16, and Levinger et al.32.  Rest followed the 1: 2 work-to-rest ratio recommended previously.
The basis of this training program was intended to follow Meyer's recommendations3.  To match
for intensity, the 1-RM for the high velocity condition was based on a high velocity 1-RM
strength test; whereas the 1-RM for the low velocity condition was based on a slow velocity test.
Each of these tests will be explained below.
The low velocity resistance exercises were performed at a rate of 6 seconds per
Day 2 Testing
Day 1 Testing
2 - 7 days
Strength Testing
2 - 7 days
Familiarization
2-7 days
Echocardiogram (if necessary)
<14 days
Recruitment
< 7 days
Screening
< 7 days
The order of high velocity
and low velocity resistance
training sessions was
randomized.
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repetition.   The concentric phase lasted 3 seconds and the eccentric phase lasted 3 seconds (i.e. 3
seconds lifting the weight and 3 seconds lowering the weight).  This velocity was based on what
was used in the low velocity training group in the healthy older adult population5,51 and what has
also been used and recommended in patients with CHF21,19.
During the high velocity condition, participants performed their contractions at a rate of 4
seconds per repetition.  The concentric phase lasted 1 second and the eccentric phase lasted 3
seconds. This velocity has been used in the older adult population in previous research4. The high
velocity group's 1-RM was based on the greatest amount of weight lifted within 1 second. A
metronome was used for the participants to control their tempo. After both sessions, participants
were then instructed to perform a cool down that would involve a low-intensity aerobic exercise
such as walking or using a stationary bicycle.
2.4 Measures
Participants were screened upon their initial visit to ensure that they fit the inclusion
criteria.  After the screening process, participants were interviewed about their medical history
and then had their height, weight, and blood pressure recorded. Participants filled out the quality
of life questionnaire (see description below).  Once these tests were completed, participants were
then familiarized with the resistance training equipment.  On the second day of testing,
participants underwent an echocardiogram to assess cardiac function if they had not had one
done in the previous 6 months.  If the participant had an echocardiogram in the previous six
months, they skipped this day of testing and the results of their previous echocardiogram were
retrieved from the participant’s medical record and used.  The third day of testing consisted of
strength testing for each exercise to determine the load for the testing days. There was at least 48
hours between each of the third, fourth, and fifth days. On the fourth and fifth days of testing,
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using random assignment, participants performed either the high- or low-velocity protocol.
During each session, heart rate, blood pressure and a rating of perceived exertion were recorded
after every set of every exercise.
2.4.1 Quality of Life
Quality of life was assessed by the Minnesota Living with Heart Failure Questionnaire
(MLHFQ).  The MLHFQ assesses the effects of heart failure on an individual's quality of life.  It
consists of twenty-one items that focus on physical and emotional aspects to assess quality of
life68. A CHF patient can score between 0 – 105 on it with a score of ‘0’ inferring the highest
quality of life and ‘105’ the lowest quality of life. It has been found to be highly reliable in
NYHA Class I & II (r = 0.87 – 0.93, α = 0.94 – 0.95)69. Mean MLHFQ scores were 21, 37, 53,
and 69 in Class I, II, III, and IV patients, respectively69. The MLHFQ is commonly used in
resistance training research studies for assessing quality of life32,19,17.
2.4.2 Strength Testing
1-RM testing on all exercises was used to determine the load for each exercise.  High
velocity 1-RM and regular 1-RM were assessed on all participants.  The high velocity 1-RM was
measured as the maximum amount of weight that was lifted with proper technique through a full
range of motion in 1 second. The regular 1-RM was measured as the maximum amount of weight
that can be lifted with proper technique through a full range of motion. The contraction tempo
was maintained by a metronome. The strength testing protocol that was used was the one that
was examined and confirmed to be safe by Werber-Zion et al13.  Each evaluation started with a
warm-up of 6-8 repetitions using a light weight. A weight of 2.5 – 10 kg was added for each
repetition until they could not lift the weight following the aforementioned criteria.  Each
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repetition was separated by at least 2 minutes of rest. Similar protocols have been used in
numerous resistance training studies in patients with CHF for strength testing32,19,17.
2.4.4 Left Ventricular Ejection Fraction
On those patients for whom echocardiography results were not obtained through a review
of the medical record, LVEF was measured by using two-dimensional echocardiography using
standardized methodology and commercially available equipment (Phillips IE33).  The left
ventricular end diastolic and end systolic diameters were measured from the parasternal long-
axis view just below the level of the mitral valve.  Anteroseptal and posterior systolic and
diastolic wall thicknesses were also measured just below the level of the mitral valve.  Ejection
fraction was calculated from these measurements. Echocardiography has been used to measure
LVEF in several prior CHF resistance training studies36,15,30,12,20.
2.4.5 Cardiovascular Stress
Cardiovascular stress was determined by measuring SBP, DBP, HR and
electrocardiography. The blood pressures and HR were recorded after every set of exercise on
day 4 and 5 of testing. The blood pressures were measured by arm auscultation in a similar
manner as Werber-Zion et al13.  The cuff was inflated near the end of the set and bled off
throughout the last 2-3 repetitions because blood pressure measures return to baseline values
within 5-10 seconds after a lift70. SBP represents the peak pressure that occurs in the arteries. It
is the pressure that is exerted on the cardiovascular system when the heart contracts. DBP
represents the lowest pressure that occurs. It is the pressure that is exerted on the cardiovascular
system while the heart is relaxed. Mean arterial pressure (MAP) was calculated from SBP and
DBP using the following formula:
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= + ( − )3
MAP represents the average blood pressure that occurs.  It is more heavily weighted on DBP
because the heart spends more time in diastole than systole.
Rate pressure product (RPP), a measure of myocardial oxygen demand, was calculated using the
following formula: = ×
HR and electrocardiography were measured by a Phillips telemetry system utilizing a three lead
hook up throughout the whole session.
2.4.6 Rating of Perceived Exertion
A rating of perceived exertion was attained after every set of exercise on days 4 and 5 of
testing.  A similar protocol was used by King et al. where a modified Borg scale was used after
every set of resistance exercise71.  The modified Borg scale ranges from '0' or a perceived
exertion of 'nothing at all' to '10' or 'Maximum'.  The participant performed a set of resistance
training and then was asked, “How hard did you feel that you were working?” and was shown
the modified Borg scale.  Their answer was then recorded.
2.5 Statistical Analysis
Dependent t-tests were used to compare HR, SBP, diastolic blood pressure, mean arterial
pressure, rate pressure product and RPE between the high velocity and low velocity exercise
sessions. Data are expressed as means (SD) unless otherwise noted. An alpha level of 0.05 was
considered statistically significant. Power was calculated using statistics software Statistica 6.0.
Demographics and quality of life measures were expressed through means and standard
deviations.
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Chapter 3
Results
3.1 Heart Rate
3.1.1 Heart Rate vs. Velocity of Contraction for All Exercises
With the average of all 5 exercises combined the HR for the low velocity session was not
significantly different from the high velocity session (p = 0.911; power = 0.38; Figure 3.1.1).
Figure 3.1.1 – Heart Rate vs. Velocity of Contraction. Individual values and mean
values are plotted. Values are in beats per minute. Error bars are standard deviations.
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3.1.2 Heart Rate vs. Velocity of Contraction for the Upper Body Exercises
With the average of the upper body exercises combined, the HR for the low velocity
session was not significantly different from the high velocity session (p = 0.639; power = 0.08;
Figure 3.1.2).
Figure 3.1.2 – Heart Rate vs. Velocity of Contraction for the Upper Body
Exercises. Individual values and mean values are plotted.Values are in beats per
minute. Error bars are standard deviations.
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3.1.3 Heart Rate vs. Velocity of Contraction for the Lower Body Exercises
With the average of the lower body exercises combined, the HR for the low velocity
session was not significantly different from the high velocity session (p = 0.914; power = 0.40;
Figure 3.1.3).
Figure 3.1.3 – Heart Rate vs. Velocity of Contraction for the Lower Body
Exercises. Individual values and mean values are plotted. Values are in beats per
minute. Error bars are standard deviations.
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3.2 Systolic Blood Pressure
3.2.1 Systolic Blood Pressure vs. Velocity of Contraction for All Exercises
With the average of all 5 exercises combined the SBP for the low velocity session was
significantly greater than the high velocity session (p <0.01; power = 0.81; Figure 3.2.1).
Figure 3.2.1 – Systolic Blood Pressure vs. Velocity of Contraction. Individual
values and mean values are plotted. Values are in milimeters of mercury. Error bars are
standard deviations.
*SBP for the low velocity session is significantly greater than for the high velocity
session (p<0.01).
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3.2.2 Systolic Blood Pressure vs. Velocity of Contraction for the Upper Body
Exercises
With the average of the upper body exercises combined, the SBP for the low velocity
session was significantly greater than the high velocity session (p <0.01; power = 0.76; Figure
3.2.2).
Figure 3.2.2 – Systolic Blood Pressure vs. Velocity of Contraction for the Upper
Body Exercises. Individual values and mean values are plotted. Values are in
milimeters of mercury. Error bars are standard deviations.
*SBP for the low velocity session is significantly greater than for the high velocity
session (p<0.01).
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3.2.3 Systolic Blood Pressure vs.Velocity of Contraction for the Lower Body
Exercises
With the average of the lower body exercises combined, the SBP for the low velocity
session was significantly greater than the high velocity session (p <0.05; power = 0.90; Figure
3.2.2).
Figure 3.2.3 – Systolic Blood Pressure vs. Velocity of Contraction for the Lower
Body Exercises. Individual values and mean values are plotted. Values are in
milimeters of mercury. Error bars are standard deviations.
*SBP for the low velocity session is significantly greater than for the high velocity
session (p<0.05).
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3.3 Diastolic Blood Pressure
3.3.1 Diastolic Blood Pressure vs. Velocity of Contraction for All Exercises
With the average of all 5 exercises combined the diastolic blood pressure for the low
velocity session was not significantly different from the high velocity session (p = 0.631; power
= 0.09; Figure 3.3.1).
Figure 3.3.1 – Diastolic Blood Pressure vs. Velocity of Contraction. Individual
values and mean values are plotted. Values are in millimeters of mercury. Error bars
are standard deviations.
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3.3.2 Diastolic Blood Pressure vs. Velocity of Contraction for the Upper Body
Exercises
With the average of the upper body exercises combined, the diastolic blood pressure for
the low velocity session was not significantly different from the high velocity session (p = 0.875;
power = 0.06; Figure 3.3.2).
Figure 3.3.2 – Diastolic Blood Pressure vs. Velocity of Contraction for the Upper
Body Exercises. Values are in millimeters of mercury. Individual values and mean
values are plotted. Error bars are standard deviations.
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3.3.3 Diastolic Blood Pressure vs. Velocity of Contraction for the Lower Body
Exercises
With the average of the lower body exercises combined, the diastolic blood pressure for
the low velocity session was not significantly different from the high velocity session (p = 0.606;
power = 0.11; Figure 3.3.3).
Figure 3.3.3 – Diastolic Blood Pressure vs. Velocity of Contraction for the Lower
Body Exercises. Individual values and mean values are plotted. Values are in
millimeters of mercury. Error bars are standard deviations.
50
55
60
65
70
75
80
85
90
Low Velocity Mean Low Velocity High Velocity High Velocity Mean
D
ia
st
ol
ic
  B
lo
od
 P
re
ss
ur
e 
(m
m
H
g)
Velocity of Contraction
Diastolic Blood Pressure vs. Velocity of Contraction for
Lower Body Exercises
30
3.4 Mean Arterial Pressure
3.4.1 Mean Arterial Pressure vs. Velocity of Contraction for All Exercises
With the average of all 5 exercises combined the mean arterial pressure for the low
velocity session was significantly greater than the high velocity session (p <0.05; power = 0.80;
Figure 3.4.1).
Figure 3.4.1 – Mean Arterial Pressure vs. Velocity of Contraction. Values are in
milimeters of mercury. Individual values and mean values are plotted. Error bars are
standard deviations.
*Mean arterial pressure for the low velocity session is significantly greater than for the
high velocity session (p<0.05).
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3.4.2 Mean Arterial Pressure vs. Velocity of Contraction for the Upper Body
Exercises
With the average of all upper body exercises combined, the mean arterial pressure for the
low velocity session was significantly greater than the high velocity session (p <0.05; power =
0.69; Figure 3.4.2).
Figure 3.4.2 – Mean Arterial Pressure vs. Velocity of Contraction for the Upper
Body Exercises. Individual values and mean values are plotted. Values are in
milimeters of mercury. Error bars are standard deviations.
*SBP for the low velocity session is significantly greater than for the high velocity
session (p<0.05).
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3.4.3 Mean Arterial Pressure vs. Velocity of Contraction for the Lower Body
Exercises
With the average of all lower body exercises combined, the mean arterial pressure for the
low velocity session was not significantly different from the high velocity session (p = 0.077;
power = 0.86; Figure 3.4.3).
Figure 3.4.3 – Mean Arterial Pressure vs. Velocity of Contraction for the Lower
Body Exercises. Individual values and mean values are plotted. Values are in
millimeters of mercury. Error bars are standard deviations.
70
75
80
85
90
95
100
105
110
Low Velocity Mean Low Velocity High Velocity High Velocity Mean
M
ea
n 
Ar
te
ria
l P
re
ss
ur
e 
(m
m
H
g)
Velocity of Contraction
Mean Arterial Pressure vs. Velocity of Contraction for
Lower Body Exercises
33
3.5 Rate Pressure Product
3.5.1 Rate Pressure Product vs. Velocity of Contraction for All Exercises
With the average of all 5 exercises combined the rate pressure product for the low
velocity session was not significantly different from the high velocity session (p = 0.106; power
= 0.38; Figure 3.5.1).
Figure 3.5.1 – Rate Pressure Product vs. Velocity of Contraction. Individual values
and mean values are plotted. Error bars are standard deviations.
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3.5.2 Rate Pressure Product vs. Velocity of Contraction for the Upper Body
Exercises
With the average of the upper body exercises combined the rate pressure product for the
low velocity session was not significantly different from the high velocity session (p = 0.063;
power = 0.69; Figure 3.5.2).
Figure 3.5.2 – Rate Pressure Product vs. Velocity of Contraction for the Upper
Body Exercises. Individual values and mean values are plotted. Error bars are
standard deviations.
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3.5.3 Rate Pressure Product vs. Velocity of Contraction for the Lower Body
Exercises
With the average of the lower body exercises combined the rate pressure product for the
low velocity session was not significantly different from the high velocity session (p = 0.166;
power = 0.29; Figure 3.5.3).
Figure 3.5.3 – Rate Pressure Product vs. Velocity of Contraction for the Lower
Body Exercises. Individual values and mean values are plotted. Error bars are
standard deviations.
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3.6 Rating of Perceived Exertion
3.6.1 Rating of Perceived Exertion vs. Velocity of Contraction for All Exercises
With the average of all 5 exercises combined the rating of perceived exertion for the low
velocity session was significantly greater than the high velocity session (p <0.05; power = 0.86;
Figure 3.6.1).
Figure 3.6.1 – Rating of Perceived Exertion vs. Velocity of Contraction. Individual
values and mean values are plotted. Error bars are standard deviations.
*Rating of perceived exertion for the low velocity session is significantly greater than
for the high velocity session (p<0.05).
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3.6.2 Rating of Perceived Exertion vs. Velocity of Contraction for the Upper Body
Exercises
With average of the upper body exercises combined, the rating of perceived exertion for
the low velocity session was not significantly different from the high velocity session (p = 0.067;
power = 0.72; Figure 3.6.2).
Figure 3.6.2 – Rating of Perceived Exertion vs. Velocity of Contraction for the
Upper Body Exercises. Individual values and mean values are plotted. Error bars are
standard deviations.
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3.6.3 Rating of Perceived Exertion vs. Velocity of Contraction for the Lower Body
Exercises
With the average of lower body exercises combined, the rating of perceived exertion for
the low velocity session was significantly greater than the high velocity session (p <0.05; power
= 0.86; Figure 3.6.3).
Figure 3.6.3 – Rating of Perceived Exertion vs. Velocity of Contraction for the
Lower Body Exercises. Individual values and mean values are plotted. Error bars are
standard deviations.
*Rating of perceived exertion for the low velocity session is significantly greater than
for the high velocity session (p<0.05).
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3.7 Mean 1-Repetition Maximum Values
3.7.1 High Velocity 1-Repetition Maximum Values
Data listed as Means ± Standard Deviation
All values are in kilograms.
Hack Squat 61.7 ± 27.0
Bench Press 30.5 ± 9.4
Knee Flexion 16.9 ± 7.3
Lat Pull -down 37.7 ± 9.7
Knee Extension 22.7 ± 10.5
Upper Body Exercises 34.1 ± 7.4
Lower Body Exercises 33.8 ± 11.2
All Exercises 33.6 ± 7.5
3.7.2 Low Velocity 1-Repetition Maximum Values
Data listed as Means ± Standard Deviation
All values are in kilograms
Hack Squat 81.2 ± 24.4
Bench Press 46.8 ± 8.6
Knee Flexion 23.7 ± 7.9
Lat Pull -down 49.4 ± 11.5
Knee Extension 29.9 ± 6.9
Upper Body Exercises 48.0 ± 9.6
Lower Body Exercises 44.9 ± 9.1
All Exercises 47.2 ± 7.6
40
Chapter 4
Discussion
4.1 Main Finding
The main finding of this investigation was that high velocity resistance training appears
to result in either more favourable or similar cardiovascular responses than low velocity
resistance training. SBP, MAP, and RPE were found to be significantly lower after the high
velocity resistance training than the low velocity session (p<0.05). HR, DBP, and RPP were not
significantly different between the high and low velocity resistance training sessions, which
suggests that the high velocity resistance training session may be as safe as low velocity
resistance training. However, the results for HR, DBP, and RPP were all underpowered (<0.80),
most likely due to low participant number. There have been no known reports of research studies
to date that have examined the effect of contraction velocity during isotonic resistance exercise
on cardiovascular and perceived responses in CHF.
4.2.1 Systolic Blood Pressure and Mean Arterial Pressure
SBP and MAP were significantly less during the high velocity resistance training session
than during the low velocity resistance training session. The exercising muscle was contracted
for 2 seconds longer per concentric contraction and this could be one of the reasons the low
velocity elicited greater SBP and MAP responses. The other reason could have been due to the
use of a higher load in the low velocity session but the response may have been washed out
because of the similar power outputs. Gaskell first examined blood flow in response to the
contraction of a muscle using dogs in 187772. He observed that during a contraction, the muscle’s
blood vessels dilate which are opposed by the mechanical compression of the contracting muscle
fibres72.  If the intensity of a static contraction is great enough, the intramuscular compression
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can impede the blood flow to the muscle73.  The mechanical compression that occurs during
muscle contractions impedes local blood flow when isometric voluntary contraction is greater
than 40-60% of maximal voluntary contraction and in our study the high velocity load was 73%
of the low velocity load65,66.  The compression of the blood vessels causes an increase in total
peripheral resistance which in turns increases SBP61.
It is difficult to compare this investigation to Degache et al.’s study examining the effect
of speed of contraction on central hemodynamics in CHF because they used a different number
repetitions, intensity, and mode (isokinetic dynamometer)47. In their study they only performed 3
maximal repetitions. They found a tendency that the highest SBP recorded was during the fastest
velocity (60 vs. 180º/s) but this was not a statistically significant finding. They did not examine
MAP. In healthy adults, the studies that have been performed are difficult to compare to our
investigation. Okamoto et al., compared high and low velocity contractions using the biceps curl
exercise67. They found that the high velocity session produced a significantly higher SBP and
MAP than the low velocity session. This finding can be attributed to the large difference in load
between the two exercise sessions. Okamoto et al. used 80% of 1-RM for the high velocity
session and only 40% of 1-RM for the low velocity session67. I used 50% of 1-RM for the low
velocity and 35.7% of 1-RM for the high velocity. The greater load at a higher velocity would
require greater muscle mass to be utilized and result in the higher SBP and MAP. Wickwire et al.
utilized a protocol comparing a 2 second concentric-4 second eccentric per rep to a super slow 10
second concentric-5 second eccentric per repetition74. They found no significant difference in
SBP and did not examine MAP between the two exercise sessions. Their high velocity was also
at a higher load than the low velocity, 65 vs. 40% of 1-RM respectively. Douris used an
isokinetic dynamometer to compare 30, 120, and 300º/s knee flexion and extension performed
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maximally for one minute58. He found no significant differences in SBP. There are a few flaws in
his study protocol. First performing maximal effort exercise for 1 minute while doing both knee
flexion and extension are going to produce high SBP with a constant increase no matter the
velocity. By performing both flexion and extension at the same time, their exercise set more
closely resembled an aerobic exercise session and would make it more difficult to detect
differences between the two velocities. Douris also did not control for the number of
repetitions58. The higher velocity performed more repetitions than the lower velocity sets.
4.2.2 Rating of Perceived Exertion
RPE was significantly less during the high velocity resistance training session than the
low velocity resistance training session. The patients with CHF in the study therefore perceived
the high velocity resistance training session to be easier than the low velocity session. This may
be important because if long term high velocity training can at least result in similar
physiological or functional benefits for CHF patients than slow velocity training, the high
velocity training would be considered to be more efficient. There are currently no resistance
training studies that have used RPE to compare any type of resistance training protocols in
patients with CHF. In healthy adults, Singh et al. compared the RPE response to three different
resistance training protocols: A power protocol consisting of 3 sets of 5 repetitions at 50% of 1-
RM at a fast lifting speed; a strength protocol consisting of 3 sets of 5 repetitions at 90% of 1-
RM; and a hypertrophy protocol consisting of 3 sets of 10 repetitions at 70% of 1-RM75. The
strength and hypertrophy produced significantly greater RPE values than the power protocol.
This study is difficult to compare to our investigation because they did not attempt to match the
power output between the power protocol and the other two protocols. The hypertrophy protocol
also had more repetitions than the power protocol which makes things even less clear but their
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results are similar to what we found. Wickwire et al. found that their super slow protocol (10
second concentric-5 second eccentric) with a lower load (40% of 1-RM) produced a significantly
lower RPE than performing a traditional machine protocol (2 seconds concentric-4 seconds
eccentric) with a higher load (65% of 1-RM)74. This makes the low velocity session easier to
perform by using a lower load than the high velocity session. The high velocity session should
have a lower load than the low velocity session in an attempt to match the overall intensity. Row
et al. compared the RPE from nine different loads where the repetition was performed as fast as
the participant was able to. RPE ratings were found to significantly predict loads relative to % of
1-RM76.
4.2.3 Rate Pressure Product
RPP was not significantly different between the high velocity and low velocity resistance
training sessions. There was a non-significant trend for RPP to be lower during the high velocity
session during the upper body exercises (p=0.063) and combined upper and lower body exercises
(p=0.106). We may have lacked statistical power for this measurement. RPP has not been used to
compare different resistance training protocols in CHF.  In healthy adults, a 300º/s protocol
elicited a significantly higher RPP than 120 and 60º/s protocols58. RPP was also significantly
greater in a high velocity protocol using 80% of 1-RM compared to a low velocity protocol that
used 40% of 1-RM67. Both studies used greater loads and Douris’ also used more repetitions for
their high velocity protocols which would elicit greater myocardial oxygen consumption and in
turn, RPP58. A significant result may have been washed out in our investigation because we did
not find significant differences in HR between the two resistance training sessions even though
SBP was significantly greater during the low velocity as compared to the high velocity.
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4.2.4 Heart Rate
HR was not significantly different between the high velocity and low velocity resistance
training sessions. This result is similar to what Degache et al. found during their CHF isokinetic
study47. They found no significant difference for HR between the 60 and 180º/s sessions. This
contradicts what has been found in the healthy population. In the study by Okamoto et al., the
high velocity session was found to have a significantly higher HR than the low velocity
session67. In the study by Wickwire et al., the traditional machine resistance protocol produced a
significantly higher HR than the super slow protocol74. Douris found that HR was significantly
greater during the 300º/s session as compared to the 30º/s58. All of the studies with healthy
populations show that the HR is highest during the resistance exercise session that uses the
highest power (highest load combined with the highest velocity of contraction). The reason that
we do not see any differences in the CHF population may be due to the medications that the CHF
population are on. Adrenergic β-antagonist (β-blocker) therapy is very common in patients with
CHF, 3 out of 7 prescribed β-blockers and the other 4 out of 7 were prescribed combined α- & β-
blockers. β-blockers are prescribed to increase coronary profusion by prolonging diastole
through a decrease in HR and myocardial contractility77. In response to a set of resistance
exercise adults taking β-blockers had a significantly lower HR than adults who were not taking
β-blockers78. β-blockers blunt the HR response to resistance exercise and this may be the reason
why there were no significant differences between the high velocity resistance training session
and the low velocity resistance training session. β-blockers are also known to decrease blood
pressure directly and indirectly; directly, β-blockers inhibit β2-adrenoreceptors located in
vascular musculature responsible for vasoconstriction; and indirectly, the decrease in HR causes
a decrease in blood pressure79.
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4.2.5 Diastolic Blood Pressure
DBP was not significantly different between the high velocity and low velocity resistance
training sessions. DBP has not been used to compare different velocities of contraction in
patients with CHF.  In healthy adults, DBP was examined in the studies by Okamoto et al. and
Douris to compare different velocities of contraction67,58. Okamoto et al. found that DBP was
significantly greater in response to the high velocity resistance exercise as compared to the low
velocity resistance exercise67. In the study by Douris, no significant differences were found in
DBP between the different isokinetic velocities58. The higher intensity resistance exercise should
elicit a significantly higher DBP than the lower intensity due to the exercise pressor reflex where
vasodilation occurs at the exercising muscle and vasoconstriction occurs in the non-exercising
areas of the body.  This may not have occurred in our study and in Douris’s study because of the
use of medications that have a vasodilatory effect or prevent vasoconstriction in patients with
CHF. These drugs are used for the treatment of hypertension. They include α-adrenoceptor
antagonists (α-blockers), angiotensin converting enzyme (ACE) inhibitors, angiotensin II
receptor antagonists also known as angiotensin receptor blockers (ARB), and calcium channel
blockers. α-blockers work by blocking α1-adrenergic receptors, which are responsible for
vasoconstriction79,80.  Blocking α1-adrenergic receptors can prevent vasoconstriction from
occurring. ACE inhibitors act mainly to decrease activation of the rennin-angiotensin-alosterone
system by preventing inactive angiotensin I from being converted to angiotensin II, the most
vasoactive product of the renin-angiotensin-aldosterone system79. Angiotensin II produces
vasoconstriction and a retention of sodium and water; inhibition of angiotensin II decreases
vasoconstriction and sodium and water80.  ARBs work in a similar manner as ACE inhibitors.
ARBs work to prevent angiotensin II from binding to the angiotensin type one receptor. ARBs
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block the angiotensin type one receptor, decreasing vasoconstriction79. Calcium channel blockers
work on the voltage-gated calcium channels of the plasma membrane. They block the
transmembrane influx of calcium through the slow channel into the vascular smooth muscle
causing a reduction of free calcium ions in the muscle tissue. This leads to a depression of
mechanical contraction of smooth muscle and depression of both impulse formation and
conduction velocity79. This causes a relaxation of the vascular smooth muscle cells and leads to
vasodilation. The exercise pressor reflex can be blunted by α-blockers, ACE inhibitors and
ARBs preventing vasoconstriction or by calcium channel blockers that negate vasoconstriction in
the non-exercising areas of the body through vasodilation and therefore prevent the increase in
DBP77. By blunting the DBP response, it makes it difficult to see significant differences between
the two exercise sessions.
4.3 Limitations
There are a few limitations to the current investigation. One obvious limitation is the low
participant number. A low participant number means that we cannot draw any definite
conclusions. This is a pilot study examining a novel training protocol in patients with CHF. This
is the first study to compare the cardiovascular effects of different velocities of contraction in
patients with CHF.
Another limitation of this study was that it was not blinded. The primary investigator
measured SBP and DBP during both the high and low velocity resistance training sessions. An
ideal design would have been to have had an independent practitioner who measured blood
pressure and was unaware of the study design. This limitation was reduced by using standardized
procedures.
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Another limitation of this study was that the researcher did not request that the
participants control their diet prior to the exercise sessions. An ideal design would have had the
participants eating a similar diet before partaking in the exercise testing sessions.
4.4 Practical Implications and Future Research
Low velocity resistance training has been determined to be safe in patients with CHF. The
results of this study suggest that it may also be safe for patients with CHF to utilize a high
velocity to perform their resistance training exercises. Future studies could examine the effect of
the high velocity training on the heart by using an echocardiogram to detect wall motion
abnormalities and other abnormalities that may occur. Future studies should examine the
effectiveness of using high velocity resistance training to improve quality of life and functional
activities in patients with CHF.
This investigation has been the first to compare different concentric resistance training
velocities that attempted to match power output. The novel method used for determining the high
velocity load will allow researchers to more accurately compare different resistance training
velocities while controlling for power output in a non-clinical setting.
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Chapter 5
Conclusions
The purpose of this study was to compare the differences between a high velocity
resistance training session and a low velocity resistance training session on central
hemodynamics and perceived exertion. This was the first study that used a similar relative
intensity for both a high and a low velocity resistance training session. SBP, MAP, and RPE were
all found to be significantly greater during the low velocity session compared to the high velocity
session. These results support part of our hypotheses and suggest that high velocity resistance
training places a smaller training load on the heart of patients with CHF than low velocity
resistance training. Patients with CHF also perceive that the high velocity session is easier to
perform than the low velocity session. Contrary to the hypotheses, RPP, DBP, and HR were not
significantly different between the low and high velocity session. Medications that patients with
CHF are managed with may affect these results. No adverse events occurred during this study
which, if replicated in a study using a greater sample size, would add to the safety of resistance
training in patients with CHF and may support the rationale for high velocity resistance training.
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Appendix A: Consent Form
Research Participant Information and Consent Form
TITLE: High versus low velocity resistance training in chronic heart failure patients.
PRINCIPAL INVESTIGATOR: Dr. Philip Chilibeck, Ph.D. College of Kinesiology,
University of Saskatchewan
SUB-INVESTIGATORS: Dr. Scott Butcher, Ph.D. School of Physical Therapy,
University of Saskatchewan
Dr. Jawed Akhtar, MD., 202-315 22nd St. E., Saskatoon,
SK; (306) 374-3278
STUDENT INVESTIGATOR: Brendan Pikaluk, B.Sc. M.Sc. Candidate. College of
Kinesiology, University of Saskatchewan (Supervised by
Dr. Phil Chilibeck & Dr. Scott Butcher) (306) 374-9762
EMERGENCY PHONE NUMBER: (306) 230-3849
INTRODUCTION
You are invited to take part in this research study because you have chronic heart failure. Your
participation is entirely voluntary, so it is up to you to decide whether or not you wish to take
part. We are seeking 45 chronic heart failure patients to complete this study.  You will not lose
the benefit of any medical care to which you are entitled or are presently receiving or lose access
to any of the recreational facilities. If you decide to take part in this study, you are still free to
withdraw at any time and without giving any reasons for your decision.
This consent form may contain words that you do not understand.  Please ask the study staff to
explain any words or information that you do not clearly understand. You may ask as many
questions as you need to understand what the study involves.  Please feel free to discuss this with
your family, friends or family physician.
STUDY PURPOSE:
Recent information indicates that resistance training should be part of a rehabilitation program
for patients with chronic heart failure.  The current guidelines do not describe the speed at which
resistance training should be done at.  The purpose of this study is to compare resistance training
protocols of high velocity, or fast speed, versus low velocity, or slow speed, to identify optimum
training protocols for patients with chronic heart failure.  We hope that the results of this study
can be applied to exercise programs for patients with chronic heart failure.
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STUDY DESIGN:
There will be three study groups. One will participate in high velocity, or fast speed, resistance
training (i.e. strength training), another will participate in low velocity, slow speed,  resistance
training and the other group will not participate in the resistance training and will continue with
the usual care and programming that you receive. You will be randomly assigned (i.e. assigned
by chance by a computer) to one of these three groups. You will have an equal chance of getting
into either group.  In addition to the time you spend exercising in the cardiac rehabilitation
program, you will be required to attend 3 exercise sessions per week for 3 months if you are
randomized into one of the resistance training groups.  Exercise sessions will last 40 minutes
each. You will be required to attend eight testing sessions as well.
STUDY PROCEDURES:
The study staff will carefully explain all procedures and you should ask whenever you need more
information. You must provide consent to participate in this study before you perform any study-
related procedures.
As a participant in this study, you will be asked to complete the following procedures:
Testing Session #1:  If you are willing to take part in the study, you will be asked to attend a
screening visit, which will last about 1.5 hours.  This will occur approximately two weeks prior
to the start of your exercise session. At this visit a certified exercise professional will check
whether you are suitable for the study:  You will be asked some questions about your medical
history and the medications you are using; and you will have a general health check up which
will include blood pressure measurements.
You will be asked to perform some functional tests by the same certified exercise professional.
These will be timed tests.  The first will require you to start from a seated position in a chair,
walk eight feet, and return to the chair.  The second test will require you to start from a seated
position again and you will have to stand up from the chair as many times as you can within 30-
seconds. The third test will time you on how fast you can climb a flight of stairs.  The last test
will have you walk as far as you can around the track for 6-minutes.
After completing these tests you will then be familiarized with the resistance training equipment
by the certified exercise professional.  This will include being taught how to use the equipment
and proper technique.  At the end of this session you will then be booked in for an
echocardiogram if you have not had one in the past 6 months.
Testing Session #2: This testing session will depend on whether you have had an echocardiogram
within the past 6 months or not.  This session will take place at Dr. Akhtar`s office and will take
approximately 1 hour.
Testing Session #3: During this testing session you will be doing strength testing with the same
exercise professional.  For each exercise you will be tested for your 1-repetition maximum, or
how much weight you can lift for one repetition.  This session will last approximately 45
minutes.  This will occur approximately one week prior to the start of the study.  Strength testing
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will occur every 2 weeks during a training session.  During the strength testing a medical doctor
will be present and cardiovascular monitoring will occur as well. The cardiovascular monitoring
we will be using is telemetry and we will use it to monitor your electrocardiograph or the rhythm
of your heart and your heart rate.
Testing Session #4 & #5: On these days of testing you will perform the workout.  One day you
will do it at the fast speed and the other day at the slower speed. Heart rate, blood pressure and a
rating of perceived exertion will be recorded after every set of every exercise.
The first 3 testing sessions will be repeated at the end of the study.
Training Sessions: Training sessions will start with a 5-minute warm-up.  The warm-up will be
followed by 40 minutes of resistance training.  The resistance training will consist of 5 different
exercises.  For each exercise you will start with 1 sets of 12 repetitions and progress to more on
an individualized basis, based on your performance during strength testing.  The high velocity
training will consist of a 1 second lifting phase and a 3 second lowering phase.  The low velocity
group will consist of a 3 second lifting phase and a 3 second lowering phase. You will then
participate in your normal endurance training that you do at the Field House, followed by a 5-
minute cool-down.
All testing and training sessions will have a physician in attendance.
BENEFITS:
If you choose to participate in this study, there may be direct benefits to you such as improved
quality of life, improvements in your activities of daily living, and an improvement in muscle
strength. However, benefits are not guaranteed.  It is hoped the information gained from this
study can be used in the future to benefit other people with a similar condition.
RISKS AND DISCOMFORTS:
The study doctor may decide that you should not perform the exercises or the exercise tests,
based on information in your medical history.  It is important that you let the study doctor or staff
know if you have ever been advised not to participate in strenuous activities.  It is also important
that you report any pain, discomfort, fatigue or other symptoms that you might have during the
exercises to the physician in attendance.
If you experience any symptoms while a participant in this study seek immediate medical
attention and inform the emergency medical personnel that you are a participant in this study.
You should then inform the study staff at 230-3849. As with any type of strenuous activity, there
is a small risk that the stress of performing exercise will cause heart rhythm abnormalities, chest
discomfort or light headedness.
Risks and discomforts will be minimized by preliminary screening and examination, by
observations made throughout the study, and through close access to emergency equipment and
medical personnel.  You will be carefully monitored throughout testing and a physician will be
immediately available in case problems should arise.  All tests will be performed by staff who are
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trained to deal with problems that may arise.  At any time during the study, it is important that
you tell the study staff if you feel unwell or experience any problems or side effects.
Due to the nature of strength testing you may experience fatigue. However, all attempts will be
made to minimize this effect, including alterations to exercise programs.
In 10 studies 232 chronic heart failure patients participated in resistance training.   The
incidences of adverse events were low.  There were only two adverse events reported.  In one
participant atrial fibrillation occurred and in the other sudden death at home three days after the
last training session occurred.  These adverse events may not have even been linked to the
training programs.  This rate of adverse events is similar to those reported from training
programs that only included endurance training.
COST AND REIMBURSEMENTS
You will not be charged for any research-related procedures. You will not be paid for
participating in this study.
RESEARCH-RELATED INJURY:
In the case of a medical emergency related to the study, you should seek immediate care and, as
soon as possible, notify the study staff. Necessary medical treatment will be made available at no
cost to you. By signing this document, you do not waive any of your legal rights.
CONFIDENTIALITY:
The researchers will protect your privacy, and safeguard the confidentiality of information
collected about you during the course of this study.  While specific measures will be taken to
maintain confidentiality, there is still a chance of unintentional release of personal information.
You will be identified in this study only by an assigned study number.  Access to your personal
health information may include copying and taking copies away.  However, in this case, all
personal identifiers would first be removed and substituted by your assigned study number.
Rarely, your study documents may be obtained by courts of law.  Reports based on results of this
study may be presented for medical and scientific publication, but your identity will not be
disclosed.  You have the right to check your research study records and health records and
request changes if the information is not correct.
With your permission, the study staff may inform your family physician of your participation in
this study.  He/she may be consulted regarding your health and treatment.
NEW INFORMATION:
The study staff will tell you about new information that may affect your health, welfare, or
willingness to stay in this study.
When this study is complete your results and the results of the study will be made available to
you upon request.
VOLUNTARY WITHDRAWAL FROM THE STUDY:
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If you do decide to take part in this study, you are still free to withdraw at any time and without
giving reasons for your decision. There will be no penalty or loss of benefits to which you are
otherwise entitled, and your future medical care or access to recreational facilities will not be
affected. If you choose to enter the study and then decide to withdraw at a later time, all data
collected about you during enrolment in the study will be retained for analysis up to the point of
your withdrawal.
WITHDRAWAL INITIATED BY THE INVESTIGATOR
You may be withdrawn from the study if:
 Staying in the study would be harmful.
 You need treatment not allowed in the study.
 You fail to follow instructions.
CONTACT INFORMATION:
If you have any questions about this study or your care/treatment or desire further information
about this study before or during participation, you can contact Brendan Pikaluk at 374-9762 or
290-9762, or Phil Chilibeck at 343-6577 or 230-9849.
If you have any questions about your rights as a research subject or concerns about the study,
you should contact the Chair of the Biomedical Research Ethics Board, c/o the Ethics Office,
University of Saskatchewan, at 306-966-4053.
This study has been reviewed and approved on ethical grounds by the University of
Saskatchewan Biomedical Research Ethics Board. The Research Ethics Board reviews human
research studies. It protects the rights and welfare of the people taking part in those studies.
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CONSENT TO PARTICIPATE
I have read (or someone has read to me) the information in this consent form.
I understand the purpose and procedures and the possible risks and benefits of the study.
I have been informed of the other treatments available for my condition.
I was given sufficient time to think about it.
I had the opportunity to ask questions and have received satisfactory answers.
I am free to withdraw from this study at any time for any reason and the decision to stop taking part will not affect
my future medical care.
I agree to follow the study staff's instructions and will tell the study staff at once if I feel I have had any unexpected
or unusual symptoms.
I have been informed there is no guarantee that this study will provide any benefits to me.
I give permission for the use and disclosure of my de-identified personal health information collected for
the research purposes described in this form.
I understand that by signing this document I do not waive any of my legal rights.
I will be given a signed and dated copy of this consent form.
My family physician can be informed about my participation in this study, and, if required, consulted regarding my
health and treatment.
 Yes, you may contact my primary care physician
 No, please do not contact my primary care physician
 I do not have a primary care physician.
(If applicable) I grant the Saskatchewan Ministry of Health permission to disclose my health care
information to the study researchers  Yes  No
I agree to participate in this study:
Printed name of participant Signature Date
Printed name of person obtaining consent Signature Date
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Appendix B: 1-RM Data Collection Sheet
SUBJECT INITIALS: _______ RECRUITMENT ID #:_________
TREATMENT: Fitness Testing
Date of measurement: ______________________
(Day/month/year)
Vital Signs
BP: ________________ (mmHg)
HR: ________________ (bpm)
Muscular Strength
1RM hack squat: Knee Angle __________ Foot Platform ____________
WARM-UP: Load ____________lbs Reps_________
High Velocity 1RM = ______________lbs
Low Velocity 1RM = ______________lbs
1RM Bench Press: Stoppers: Up    Down
WARM-UP: Load ____________lbs Reps_________
High Velocity 1RM = ______________lbs
Low Velocity 1RM = ______________lbs
1RM Knee Flexion
WARM-UP: Load ____________lbs Reps_________
High Velocity 1RM = ______________lbs
Low Velocity 1RM = ______________lbs
1RM Lat Pull Down
WARM-UP: Load ____________lbs Reps_________
High Velocity 1RM = ______________lbs
Low Velocity 1RM = ______________lbs
1RM Knee Extension
WARM-UP: Load ____________lbs Reps_________
High Velocity 1RM = ______________lbs
Low Velocity 1RM = ______________lbs
Form Complete by: ____________________ Date: _________________________
Signature of PI: ________________________ Date: _________________________
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Appendix C: Resistance Training Session Data Sheet
SUBJECT INITIALS: _______ RECRUITMENT ID #:_________
TREATMENT: _______ Velocity Workout
Date of measurement: ______________________
(Day/month/year)
Vital Signs
BP: ________________ (mmHg)
HR: ________________ (bpm)
Hack squat: Knee Angle __________Foot Platform ____________
Load ____________lbs Reps_________
Blood Pressure = ______________mmHg
Heart Rate        = ______________bpm
RPE                  = ______________
Bench Press: Stoppers: Up    Down
Load ____________lbs Reps_________
Blood Pressure = ______________mmHg
Heart Rate        = ______________bpm
RPE                  = ______________
Knee Flexion
Load ____________lbs Reps_________
Blood Pressure = ______________mmHg
Heart Rate        = ______________bpm
RPE                  = ______________
Lat Pull Down
Load ____________lbs Reps_________
Blood Pressure = ______________mmHg
Heart Rate        = ______________bpm
RPE                  = ______________
Knee Extension
Load ____________lbs Reps_________
Blood Pressure = ______________mmHg
Heart Rate        = ______________bpm
RPE                  = ______________
Form Complete by: ____________________ Date: _________________________
Signature of PI: ________________________ Date: _________________________
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Appendix D: Rating of Perceived Exertion Scale
0 NOTHING AT ALL
0.5 VERY, VERY LIGHT
1 VERY LIGHT
2 FAIRLY LIGHT
3 MODERATE
4 SOMEWHAT HARD
5 HARD
6
7 VERY HARD
8
9
10 VERY VERY HARD (MAXIMAL)
